SEC Form 4 · accession 0001069530-17-000034
PAIN THERAPEUTICS INC · PTIE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nadav Friedmann
Officer — Chief Scientific Officer · Director
Period of report
Aug 23, 2017
Accepted (ET)
Aug 24, 2017 · 5:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069530
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options(1) | $3.24 | Aug 23, 2017 | A | 250,000 | A | Sep 23, 2017 | Aug 23, 2027 | Common Stock | 250,000 | 639,238 | D |
Remarks
(1)Stock option vest over four (4) years period at a rate of 1/48th per month.